Literature DB >> 22330949

Psoriasis: issues far more serious than cosmetic.

Guido R Zanni1.   

Abstract

Psoriasis-the most prevalent autoimmune disease in the United States-is a chronic, relapsing disease with variable clinical features and triggers that are both genetic and environmental. Psoriasis is an independent risk factor for mortality and is linked to numerous comorbidities, including cardiovascular disease, clinical depression, diabetes, cancer, Crohn's disease, hypertension, obesity, metabolic syndrome, liver disease, infections, dyslipidemia, and osteoporosis. While there is no cure, topical medications, phototherapy, traditional systemic agents, and biologics offer a wide array of options for management of symptoms. A combination of agents is frequently needed for moderate-to-severe cases, and positive long-term outcomes require medication adherence. Significant knowledge gaps exist on disease onset and progression along with a lack of comparative-effectiveness research on treatment regimens.

Entities:  

Mesh:

Year:  2012        PMID: 22330949     DOI: 10.4140/TCP.n.2012.86

Source DB:  PubMed          Journal:  Consult Pharm        ISSN: 0888-5109


  2 in total

1.  Oral granulated Chinese herbal medicine (YXBCM01) plus topical calcipotriol for psoriasis vulgaris: study protocol for a double-blind, randomized placebo controlled trial.

Authors:  Shefton Parker; Anthony Lin Zhang; Claire Shuiqing Zhang; Greg Goodman; Zehuai Wen; Chuanjian Lu; Charlie Changlie Xue
Journal:  Trials       Date:  2014-12-19       Impact factor: 2.279

2.  The Temperament Risk Factor, Disease Severity, and Quality of Life in Patients with Psoriasis.

Authors:  Konrad Janowski; Stanisława Steuden
Journal:  Ann Dermatol       Date:  2020-11-11       Impact factor: 1.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.